As pharm execs look to real-world data to aid in translational research and close the gap from traditional clinical trials to real-world efficacy, there are three foundational pillars to build from. Bill Fox reports.
Bill Fox
Advertisement
Bill Fox is Chief Strategist, Global Healthcare, Life Sciences and Insurance at MarkLogic
Articles by Bill Fox
Advertisement
Latest Updated Articles
- The Genetic Data Gold Rush: Balancing Privacy and Health Outcomes
Published: October 18th 2018 | Updated: